{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:23:13Z","timestamp":1772500993532,"version":"3.50.1"},"reference-count":48,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T00:00:00Z","timestamp":1647129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Delta variant has evolved to become the dominant SARS-CoV-2 lineage with multiple sub-lineages and there are also reports of re-infections caused by this variant. We studied the disease characteristics induced by the Delta AY.1 variant and compared it with the Delta and B.1 variants in Syrian hamsters. We also assessed the potential of re-infection by these variants in Coronavirus disease 2019 recovered hamsters 3 months after initial infection. The variants produced disease characterized by high viral load in the respiratory tract and interstitial pneumonia. The Delta AY.1 variant produced mild disease in the hamster model and did not show any evidence of neutralization resistance due to the presence of the K417N mutation, as speculated. Re-infection with a high virus dose of the Delta and B.1 variants 3 months after B.1 variant infection resulted in reduced virus shedding, disease severity and increased neutralizing antibody levels in the re-infected hamsters. The reduction in viral load and lung disease after re-infection with the Delta AY.1 variant was not marked. Upper respiratory tract viral RNA loads remained similar after re-infection in all the groups. The present findings show that prior infection could not produce sterilizing immunity but that it can broaden the neutralizing response and reduce disease severity in case of reinfection.<\/jats:p>","DOI":"10.3390\/v14030596","type":"journal-article","created":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T21:44:17Z","timestamp":1647207857000},"page":"596","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters"],"prefix":"10.3390","volume":"14","author":[{"given":"Sreelekshmy","family":"Mohandas","sequence":"first","affiliation":[{"name":"Indian Council of Medical Research-National Institute of Virology, Pune 411021, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0861-7166","authenticated-orcid":false,"given":"Pragya D.","family":"Yadav","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-National Institute of Virology, Pune 411021, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Shete","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-National Institute of Virology, Pune 411021, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimpal","family":"Nyayanit","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-National Institute of Virology, Pune 411021, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajlaxmi","family":"Jain","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-National Institute of Virology, Pune 411021, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gajanan","family":"Sapkal","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-National Institute of Virology, Pune 411021, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrashekhar","family":"Mote","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathology, Krantisinh Nana Patil College of Veterinary Science, Shirwal 412801, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,13]]},"reference":[{"key":"ref_1","unstructured":"(2021, November 19). PANGO Lineages. Available online: https:\/\/cov-lineages.org\/global_report_B.1.617.2.html."},{"key":"ref_2","unstructured":"World Health Organization (2021, November 19). Available online: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---16-november-2021."},{"key":"ref_3","unstructured":"Pan American Health Organisation (2021, December 11). Available online: https:\/\/www.paho.org\/en\/documents\/epidemiological-update-coronavirus-disease-covid-19-2-december-2021."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/CDLI.11.4.665-668.2004","article-title":"Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus","volume":"11","author":"Woo","year":"2004","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-020-1083-1","article-title":"Seasonal coronavirus protective immunity is short-lasting","volume":"26","author":"Edridge","year":"2020","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Prado-Vivar, B., Becerra-Wong, M., Guadalupe, J.J., Marquez, S., Gutierrez, B., Rojas-Silva, P., Grunauer, M., Trueba, G., Barragan, V., and Cardenas, P. (2021, November 19). COVID-19 Re-Infection by a Phylogenetically Distinct SARS-CoV-2 Variant, First Confirmed Event in South America. Available online: https:\/\/ssrn.com\/abstract=3686174.","DOI":"10.2139\/ssrn.3686174"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1473-3099(20)30764-7","article-title":"Genomic evidence for reinfection with SARS-CoV-2: A case study","volume":"21","author":"Tillett","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/ciaa1330","article-title":"Symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection by a phylogenetically distinct strain","volume":"73","author":"Vermeersch","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e2946","DOI":"10.1093\/cid\/ciaa1275","article-title":"COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing","volume":"73","author":"To","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/jim-2021-001853","article-title":"COVID-19 reinfection: A rapid systematic review of case reports and case series","volume":"69","author":"Wang","year":"2021","journal-title":"J. Investig. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chom.2021.04.007","article-title":"Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization","volume":"29","author":"Wang","year":"2021","journal-title":"Cell Host Microb."},{"key":"ref_13","unstructured":"Centre for Disease Control and Prevention (2021, November 19). Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/duration-isolation.html."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jamainternmed.2021.2959","article-title":"Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy","volume":"181","author":"Vitale","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Shastri, J., Parikh, S., Aggarwal, V., Agrawal, S., Chatterjee, N., Shah, R., Devi, P., Mehta, P., and Pandey, R. (2021). Severe SARS-CoV-2 Breakthrough Reinfection with Delta Variant After Recovery from Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker. Front. Med., 8.","DOI":"10.3389\/fmed.2021.737007"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fmed.2021.631769","article-title":"Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients from Mumbai, India","volume":"8","author":"Shastri","year":"2021","journal-title":"Front. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mohandas, S., Yadav, P.D., Shete, A., Nyayanit, D., Sapkal, G., Lole, K., and Gupta, N. (2021). SARS-CoV-2 Delta variant pathogenesis and host response in Syrian hamsters. Viruses, 13.","DOI":"10.3390\/v13091773"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/22221751.2021.1913974","article-title":"Protection against reinfection with D614-or G614-SARS-CoV-2 isolates in golden Syrian hamster","volume":"10","author":"Brustolin","year":"2021","journal-title":"Emer. Microbes Infect."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Selvaraj, P., Lien, C.Z., Liu, S., Stauft, C.B., Nunez, I.A., Hernandez, M., Nimako, E., Ortega, M.A., Starost, M.F., and Dennis, J.U. (2021). SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters. Life Sci. Alliance, 4.","DOI":"10.26508\/lsa.202000886"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Halfmann, P.J., Kuroda, M., Armbrust, T., Accola, M., Valdez, R., Kowalski-Dobson, T., Rehrauer, W., Gordon, A., and Kawaoka, Y. (2022). Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model. Cell Rep., 31.","DOI":"10.2139\/ssrn.3910715"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"key":"ref_23","unstructured":"European Centre for Disease Prevention and Control (2021, November 19). Available online: https:\/\/www.ecdc.europa.eu\/en\/covid-19\/variants-concern."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/ijmr.IJMR_671_20","article-title":"Development of in Vitro Transcribed RNA as Positive Control for Laboratory Diagnosis of SARS-CoV-2 in India","volume":"151","author":"Choudhary","year":"2020","journal-title":"Indian J. Med. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jinf.2020.11.034","article-title":"Test on Stool Samples Improves the Diagnosis of Hospitalized Patients: Detection of SARS-CoV-2 genomic and subgenomic RNA","volume":"82","author":"Moreira","year":"2021","journal-title":"J. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Shete, A., Mohandas, S., Jain, R., and Yadav, P.D. (2021). A qualitative IgG ELISA for detection of SARS-CoV-2-specific antibodies in Syrian hamster serum samples. STAR Protoc., 2.","DOI":"10.1016\/j.xpro.2021.100573"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/ijmr.IJMR_2382_20","article-title":"Neutralizing Antibody Responses to SARS-CoV-2 in COVID-19 Patients","volume":"152","author":"Deshpande","year":"2020","journal-title":"Indian J. Med. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/s41423-021-00772-y","article-title":"Delta variant (B. 1.617. 2) sublineages do not show increased neutralization resistance","volume":"18","author":"Arora","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S1473-3099(21)00580-6","article-title":"Hospitalisation associated with SARS-CoV-2 delta variant in Denmark","volume":"21","author":"Bager","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","article-title":"Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: A cohort study","volume":"22","author":"Twohig","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41379-020-0603-3","article-title":"A systematic review of pathological findings in COVID-19: A pathophysiological timeline and possible mechanisms of disease progression","volume":"33","author":"Polak","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1165\/rcmb.2020-0280LE","article-title":"Standardization of reporting criteria for lung pathology in SARS-CoV-2\u2013infected hamsters: What matters?","volume":"63","author":"Gruber","year":"2020","journal-title":"Am. J. Respir. Cell Mol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Yadav, P.D., Sahay, R.R., Sapkal, G., Nyayanit, D., Shete, A.M., Deshpande, G., Patil, D.Y., Gupta, N., Kumar, S., and Abraham, P. (2021). Comparable neutralization of SARS-CoV-2 Delta AY. 1 and Delta in individuals sera vaccinated with BBV152. J. Travel Med., 28.","DOI":"10.1093\/jtm\/taab154"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Rabaan, A.A., Al-Ahmed, S.H., Muhammad, J., Khan, A., Sule, A.A., Tirupathi, R., Mutair, A.A., Alhumaid, S., Al-Omari, A., and Dhawan, M. (2021). Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines, 9.","DOI":"10.3390\/vaccines9050436"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Merza, M.Y., Hwaiz, R.A., Hamad, B.K., Mohammad, K.A., Hama, H.A., and Karim, A.Y. (2021). Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0250330"},{"key":"ref_38","first-page":"263","article-title":"IL-6 is a biomarker for the development of fatal SARS-CoV-2 pneumonia","volume":"12","author":"Oliveira","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Francis, M.E., Goncin, U., Kroeker, A., Swan, C., Ralph, R., Lu, Y., Etzioni, A.L., Falzarano, D., Gerdts, V., and Machtaler, S. (2021). SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney. PLos Pathog., 17.","DOI":"10.1101\/2021.04.07.438843"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fmicb.2019.01057","article-title":"The role of interleukin 6 during viral infections","volume":"10","author":"Rodriguez","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.immuni.2021.07.008","article-title":"Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations","volume":"54","author":"Muecksch","year":"2021","journal-title":"Immunity"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhang, C., Guo, Z., Li, N., Cui, H., Meng, K., Liu, L., Zhao, L., Zhang, S., Qin, C., and Liu, J. (2021). Impact of Prior Infection on Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Syrian Hamsters. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.722178"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.abc4776","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques","volume":"369","author":"Chandrashekar","year":"2020","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41577-021-00550-x","article-title":"Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection","volume":"21","author":"Cromer","year":"2021","journal-title":"Nat. Rev. Immunol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/3\/596\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:35:56Z","timestamp":1760135756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/3\/596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,13]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["v14030596"],"URL":"https:\/\/doi.org\/10.3390\/v14030596","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.11.28.470293","asserted-by":"object"}]},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,13]]}}}